Cytarabine

NDC 61703-304 · Hospira, Inc.

Generic nameCYTARABINE

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)CYTARABINE

Strength20 mg/mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

61703-304-36 — 1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) / 25 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9100 — Injection, cytarabine, 100 mg Medicare Part B payment limit (ASP + 6%): $0.85

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-223 — cytarabine, 25021-229 — cytarabine, 61703-155 — CYTARABINE, 61703-303 — CYTARABINE, 61703-305 — CYTARABINE, 61703-319 — CYTARABINE, 63323-120 — CYTARABINE, 68083-337 — Cytarabine, 68083-343 — Cytarabine, 68727-745 — (daunorubicin and cytarabine) liposome, 71288-108 — Cytarabine, 71288-109 — Cytarabine, 71288-168 — Cytarabine, 71288-169 — Cytarabine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources